EuroPCR 2026

21 May 2026

TAVI

TAVI vs. surgery - Are the latest long-term data creating a dilemma for aortic stenosis patients?

Sponsored by Edwards Lifesciences

Anchorperson: T. Pilgrim

Spokesperson: M. Joner

SHOW MORE

Summary

This session critically evaluates the latest long-term data comparing transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR). It explores differing perspectives between surgeons and interventional cardiologists regarding valve durability and lifetime management, fostering a high-quality debate to achieve consensus within Heart Team discussions on the best procedural choices for aortic stenosis patients.

Learning Objectives

To explore the latest data on TAVI and SAVR durability and their impact on patients
To understand the potentially different interpretations of surgeons and interventional cardiologists regarding the new evidence, and how consensus can be reached in Heart Team discussions
To appreciate a high‑quality debate on the impact of valve durability on the choice of the most appropriate procedure

Thomas Pilgrim

Speaker

Welcome and session objectives

Download presentation

Dr. Martin B. Leon

Speaker

The theory - Summary of the latest TAVI vs. SAVR data

Download presentation

Speaker

Surgery offers the superior long-term lifetime management

Download presentation

Speaker

Even young patients prefer TAVI, and they are right!

Download presentation